NEW YORK, April 19 (Reuters) - Wyeth on Thursday said it still expects in the third quarter to launch its Pristiq drug in the United States to treat hot flashes, despite the need by regulators to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback